Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper: Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://ncbi.nlm.nih.gov/pubmed/27764779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12737
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller